Spike RBD Antibody (1042425) [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # FAB10827JF669
Conjugate
Catalog #
Key Product Details
Species Reactivity
SARS-CoV-2
Applications
Flow Cytometry, Immunocytochemistry, Western Blot
Label
Janelia Fluor 669
Antibody Source
Monoclonal Mouse IgG2A Clone # 1042425
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Chinese Hamster Ovary cell line CHO-derived SARS-CoV Spike RBD
Arg306-Phe527
Accession # NP_0828851.1
Arg306-Phe527
Accession # NP_0828851.1
Specificity
Detects SARS-CoV Spike RBD in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for Spike RBD Antibody (1042425) [Janelia Fluor® 669]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
0
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Spike RBD
Long Name
Spike Receptor Binding Domain
Additional Spike RBD Products
Product Documents for Spike RBD Antibody (1042425) [Janelia Fluor® 669]
Product Specific Notices for Spike RBD Antibody (1042425) [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...